✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals

Dr Lalchandani Labs Ltd.

DLCL

Market Cap
₹6 Cr.
P/E
15.29

Dr Lalchandani Labs Ltd.

  • Dr Lalchandani Labs
  • Looks Health Service
  • Clinitech Laboratory
FAQs on Dr Lalchandani Labs Ltd. Shareprice

Dr Lalchandani Labs has given lower returns compared to its competitors.
Dr Lalchandani Labs has grown at ~8.97% over the last 5yrs while peers have grown at a median rate of 20.36%

Dr Lalchandani Labs is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Dr Lalchandani Labs is 15.29, while 3 year average PE is 10.81.
Also latest EV/EBITDA of Dr Lalchandani Labs is 0 while 3yr average is 13.75.

View FAQ's On Business
Growth Table
  • Dr Lalchandani Labs Ltd.
  • Looks Health Service
  • Clinitech Laboratory
Balance Sheet
  • Dr Lalchandani Labs Ltd.
  • Looks Health Service
  • Clinitech Laboratory
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Dr Lalchandani Labs Ltd.
  • Looks Health Service
  • Clinitech Laboratory
Cash Flow
  • Dr Lalchandani Labs Ltd.
  • Looks Health Service
  • Clinitech Laboratory
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Dr Lalchandani Labs Ltd.
  • Looks Health Service
  • Clinitech Laboratory
Quarterly Results
  • Dr Lalchandani Labs Ltd.
  • Looks Health Service
  • Clinitech Laboratory
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Dr Lalchandani Labs Ltd. Financials

Dr Lalchandani Labs balance sheet is weak and might have solvency issues

The net debt of Dr Lalchandani Labs is decreasing.
Latest net debt of Dr Lalchandani Labs is ₹0.77 Crs as of Mar-25.
This is less than Mar-24 when it was ₹1.28 Crs.

The profit is oscillating.
The profit of Dr Lalchandani Labs is ₹0.62 Crs for Mar 2024, -₹1.56 Crs for Mar 2023 and ₹0.93 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Dr Lalchandani Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech